Morocco | COVID-19 Export authorisations for pharma and medical products

Description of measures:

Date and reference of the domestic legal act imposing the contested measure:Circular 91/DMP00 of 31/3/2020 of the Ministry of health

Factual description of the measure:

In order to ensure sufficient supplies of pharmaceutical products for the domestic market, exports are subject to a system of ad hoc authorisation based, inter alia, on the availability of local stocks.

Product(s) affected 

All pharmaceutical products. In practice, extended to other medical products (except masks which are subject to export licence)

CONTINUE READING ON: madb.europa.eu